Cumulative risk of cardiovascular events after orthotopic liver transplantation

Liver Transplantation

Volumn 18, Issue 3, 2012, Pages 370-375

  Albeldawi, Mazen ^a   Aggarwal, Ashish ^a   Madhwal, Surabhi ^b   Cywinski, Jacek ^a   Lopez, Rocio ^a   Eghtesad, Bijan ^a   Zein, Nizar N ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; DIABETES MELLITUS; END STAGE LIVER DISEASE; FEMALE; FOLLOW UP; HEPATITIS C VIRUS; HUMAN; HYPERTENSION; KAPLAN MEIER METHOD; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE DIABETES MELLITUS; POSTTRANSPLANT HYPERTENSION; POSTTRANSPLANT METABOLIC SYNDROME; PRIORITY JOURNAL; TREATMENT INDICATION;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 84857582343     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22468     Document Type: Article

References (15)

1. Pruthi J, Medkiff KA, Esrason KT, Donovan JA, Yoshida EM, Erb SR, et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl 2001; 7: 811-815. (Pubitemid 32851304)
2. Zein CO, Levy C, Basu A, Zein NN,. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol 2005; 100: 48-55. (Pubitemid 41623268)
3. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al.; for American Heart Association, American Stroke Association Council on Stroke, Council on Cardiovascular Radiology and Intervention, and American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37: 577-617. (Pubitemid 43732031)
4. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L,. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004; 10: 886-897. (Pubitemid 38979259)
5. Laryea M, Watt KD, Molinari M, Walsh MJ, McAlister VC, Marotta PJ, et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl 2007; 13: 1109-1114. (Pubitemid 47305029)
6. Francioso S, Angelico F, Baiocchi L, Tisone G, Lenci I, Carbone M, Angelico M,. High prevalence of metabolic syndrome and long-term survival after liver transplantation. J Hepatol 2008; 48 (suppl 2): S82.
7. Hanouneh IA, Feldstein AE, McCullough AJ, Miller C, Aucejo F, Yerian L, et al. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl 2008; 14: 1287-1293.
8. Bianchi G, Marchesini G, Marzocchi R, Pinna AD, Zoli M,. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl 2008; 14: 1648-1654.
9. Ford ES, Giles WH, Dietz WH,. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359. (Pubitemid 34251969)
10. Abbasoglu O, Levy MF, Brkic BB, Testa G, Jeyarajah DR, Goldstein RM, et al. Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation 1997; 64: 1801-1807. (Pubitemid 28041721)
11. Guckelberger O, Byram A, Klupp J, Neumann UP, Glanemann M, Stockmann M, et al. Coronary event rates in liver transplant recipients reflect the increased prevalence of cardiovascular risk-factors. Transpl Int 2005; 18: 967-974. (Pubitemid 41726797)
12. Neal DA, Tom BD, Luan J, Wareham NJ, Gimson AE, Delriviere LD, et al. Is there disparity between risk and incidence of cardiovascular disease after liver transplant? Transplantation 2004; 77: 93-99. (Pubitemid 38116878)
13. Eckel RH, Grundy SM, Zimmet PZ,. The metabolic syndrome. Lancet 2005; 365: 1415-1428. (Pubitemid 40523737)
14. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y,. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996; 2: 426-430. (Pubitemid 26386861)
15. Balamuthusamy S, Srinivasan L, Verma M, Adigopula S, Jalandhara N, Hathiwala S, Smith E,. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis. Am Heart J 2008; 155: 791-805. (Pubitemid 351601744)